health · education · HHS-NIH11
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
National Institutes of Health · PA-25-253
Deadline
September 7, 2028
GRANTQUICK SUMMARYPlain-English Overview
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional). National Institutes of Health. This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and... Funding amounts not specified.
Who Should Apply
Public And Indian Housing Authorities, Federally Recognized Native American Tribal Governments, Special district governments, State governments, City/township governments (+10 more)
Who Should NOT Apply
Organizations not matching the eligible applicant types listed above
Key Requirements (Plain English)
- •Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Is...
- •Deadline: 2028-09-07
💡 GrantQuick Tip
Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.
Competitiveness: Moderate to high — federal grants are always competitive
What This Grant Funds
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Cost Sharing Required?
- No
- Funding Instrument
- grant
Key Dates
Agency Contact
NIH Grants Information grantsinfo@nih.gov
grantsinfo@nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov